Publications

  1. Sun HY, Alexander BD, Huprikar S, Forrest GN, Bruno D, Lyon GM, Wray D, Johnson LB, Sifri CD, Razonable RR, Morris MI, Stoser V, Wagener MM, Singh N. Predictors of immune reconstitution syndrome in organ transplant recipients with cryptococcosis: implications for the management of immunosuppression. Clin Infect Dis. 2015 Jan 1; 60(1):36-44. Epub 2014 Sep 09.
    View PubMed
  2. Bruminhent J, Deziel PJ, Wotton JT, Binnicker MJ, Razonable RR. Prolonged shedding of pandemic influenza A (H1N1) 2009 virus in a pancreas-after-kidney transplant recipient. J Clin Virol. 2014 Oct; 61(2):302-4. Epub 2014 Jul 16.
    View PubMed
  3. Ramanan P, Deziel PJ, Norby SM, Yao JD, Garza I, Razonable RR. Donor-transmitted HTLV-1-associated myelopathy in a kidney transplant recipient--case report and literature review. Am J Transplant. 2014 Oct; 14(10):2417-21. Epub 2014 Aug 19.
    View PubMed
  4. Bruminhent J, Razonable RR. Outcomes of patients with cytomegalovirus viremia at the time of liver transplantation. Liver Transpl. 2014 Sep; 20(9):1029-33. Epub 2014 Aug 04.
    View PubMed
  5. Melendez D, Razonable RR. Immune-based monitoring for cytomegalovirus infection in solid organ transplantation: is it ready for clinical primetime? Expert Rev Clin Immunol. 2014 Sep; 10(9):1213-27. Epub 2014 Jul 31.
    View PubMed
  6. Beam E, Dioverti V, Razonable RR. Emerging cytomegalovirus management strategies after solid organ transplantation: challenges and opportunities. Curr Infect Dis Rep. 2014 Sep; 16(9):419.
    View PubMed
  7. Marcelin JR, Beam E, Razonable RR. Cytomegalovirus infection in liver transplant recipients: Updates on clinical management. World J Gastroenterol. 2014 Aug 21; 20(31):10658-67.
    View PubMed
  8. Khare R, Gupta S, Arif S, Jentoft ME, Deziel PJ, Roden AC, Wilhelm MP, Razonable RR, Wengenack NL. Misidentification of Neosartorya pseudofischeri as Aspergillus fumigatus in a lung transplant patient. J Clin Microbiol. 2014 Jul; 52(7):2722-5. Epub 2014 May 14.
    View PubMed
  9. Bruminhent J, Razonable RR. Management of cytomegalovirus infection and disease in liver transplant recipients. World J Hepatol. 2014 Jun 27; 6(6):370-83.
    View PubMed
  10. Ariza-Heredia EJ, Beam EN, Lesnick TG, Cosio FG, Kremers WK, Razonable RR. Impact of urinary tract infection on allograft function after kidney transplantation. Clin Transplant. 2014 Jun; 28(6):683-90. Epub 2014 Apr 27.
    View PubMed
  11. Vergidis P, Razonable RR, Wheat LJ, Estes L, Caliendo AM, Baden LR, Wingard JR, Baddley J, Assi M, Norris S, Chandrasekar P, Shields R, Nguyen H, Freifeld A, Kohler R, Kleiman M, Walsh TJ, Hage CA. Reduction in false-positive Aspergillus serum galactomannan enzyme immunoassay results associated with use of piperacillin-tazobactam in the United States. J Clin Microbiol. 2014 Jun; 52(6):2199-201. Epub 2014 Apr 09.
    View PubMed
  12. Ramanan P, Deziel PJ, Razonable RR. Rhodococcus globerulus bacteremia in an allogeneic hematopoietic stem cell transplant recipient: report of the first transplant case and review of the literature. Transpl Infect Dis. 2014 Jun; 16(3):484-9. Epub 2014 May 02.
    View PubMed
  13. Marcelin JR, Wilson JW, Razonable RR, Mayo Clinic Hematology/Oncology and Transplant Infectious Diseases Services. Oral ribavirin therapy for respiratory syncytial virus infections in moderately to severely immunocompromised patients. Transpl Infect Dis. 2014 Apr; 16(2):242-50. Epub 2014 Mar 13
    View PubMed
  14. Dave M, Purohit T, Razonable R, Loftus EV Jr. Opportunistic infections due to inflammatory bowel disease therapy. Inflamm Bowel Dis. 2014 Jan; 20(1):196-212.
    View PubMed
  15. Bruminhent J, Razonable RR. Diagnosis, Prevention and Treatment of Cytomegalovirus Disease in Liver Transplant Recipients World Journal of Hepatology. 2014; in press.
  16. Ramanan P, Razonable RR. Elizabethkingia species sepsis after lung transplantation: case report and literature review. Transpl Infect Dis. 2013 Dec; 15(6):E229-34. Epub 2013 Oct 14.
    View PubMed
  17. Reid G, Huprikar S, Patel G, Razonable RR, Mossad S, Levi M, Gregg K, Shoham S, Humar A, Adams W, Kumar D. A multicenter evaluation of pandemic influenza A/H1N1 in hematopoietic stem cell transplant recipients. Transpl Infect Dis. 2013 Oct; 15(5):487-92. Epub 2013 Jul 25.
    View PubMed
  18. Razonable RR, Hayden RT. Clinical utility of viral load in management of cytomegalovirus infection after solid organ transplantation. Clin Microbiol Rev. 2013 Oct; 26(4):703-27.
    View PubMed
  19. Ramanan P, Razonable RR. Cytomegalovirus infections in solid organ transplantation: a review. Infect Chemother. 2013 Sep; 45(3):260-71. Epub 2013 Sep 27.
    View PubMed
  20. Razonable RR, Asberg A, Rollag H, Duncan J, Boisvert D, Yao JD, Caliendo AM, Humar A, Do TD. Virologic suppression measured by a cytomegalovirus (CMV) DNA test calibrated to the World Health Organization international standard is predictive of CMV disease resolution in transplant recipients. Clin Infect Dis. 2013 Jun; 56(11):1546-53. Epub 2013 Feb 15.
    View PubMed
  21. Chong PP, Razonable RR. Diagnostic and management strategies for donor-derived infections. Infect Dis Clin North Am. 2013 Jun; 27(2):253-70. Epub 2013 Mar 26.
    View PubMed
  22. Razonable RR. Management strategies for cytomegalovirus infection and disease in solid organ transplant recipients. Infect Dis Clin North Am. 2013 Jun; 27(2):317-42. Epub 2013 Mar 26.
    View PubMed
  23. Lee SO, Brown RA, Razonable RR. Association between a functional polymorphism in Toll-like receptor 3 and chronic hepatitis C in liver transplant recipients. Transpl Infect Dis. 2013 Apr; 15(2):111-9. Epub 2012 Dec 13.
    View PubMed
  24. Razonable RR, Humar A, AST Infectious Diseases Community of Practice. Cytomegalovirus in solid organ transplantation. Am J Transplant. 2013 Mar; 13 Suppl 4:93-106.
    View PubMed
  25. Razonable RR. Human herpesviruses 6, 7 and 8 in solid organ transplant recipients. Am J Transplant. 2013 Feb; 13 Suppl 3:67-77; quiz 77-8.
    View PubMed
  26. Ariza-Heredia EJ, Beam EN, Lesnick TG, Kremers WK, Cosio FG, Razonable RR. Urinary tract infections in kidney transplant recipients: role of gender, urologic abnormalities, and antimicrobial prophylaxis. Ann Transplant. 2013; 18:195-204. Epub 2013 May 06.
    View PubMed
  27. Beam E, Razonable RR. Cytomegalovirus in solid organ transplantation: epidemiology, prevention, and treatment. Curr Infect Dis Rep. 2012 Dec; 14(6):633-41.
    View PubMed
  28. Vergidis P, Lesnick TG, Kremers WK, Razonable RR. Prosthetic joint infection in solid organ transplant recipients: a retrospective case-control study. Transpl Infect Dis. 2012 Aug; 14(4):380-6. Epub 2012 Jan 20.
    View PubMed
  29. Lee SO, Brown RA, Razonable RR. Chromosomally integrated human herpesvirus-6 in transplant recipients. Transpl Infect Dis. 2012 Aug; 14(4):346-54. Epub 2012 Feb 09.
    View PubMed
  30. Ariza-Heredia EJ, Patel R, Blumberg EA, Walker RC, Lewis R, Evans J, Sankar A, Willliams MD, Rogers J, Milano C, Razonable RR. Outcomes of transplantation using organs from a donor infected with Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae. Transpl Infect Dis. 2012 Jun; 14(3):229-36. Epub 2012 May 25.
    View PubMed
  31. Tapia GG, Razonable RR, Eckel-Passow JE, Lahr BD, Afessa B, Keegan MT, Catania J, Baddour LM. A scoring model of factors associated with Candida glabrata candidemia among critically ill patients. Mycoses. 2012 May; 55(3):228-36. Epub 2011 Jul 21.
    View PubMed
  32. Lautenschlager I, Razonable RR. Human herpesvirus-6 infections in kidney, liver, lung, and heart transplantation: review. Transpl Int. 2012 May; 25(5):493-502. Epub 2012 Feb 23.
    View PubMed
  33. Pellett PE, Ablashi DV, Ambros PF, Agut H, Caserta MT, Descamps V, Flamand L, Gautheret-Dejean A, Hall CB, Kamble RT, Kuehl U, Lassner D, Lautenschlager I, Loomis KS, Luppi M, Lusso P, Medveczky PG, Montoya JG, Mori Y, Ogata M, Pritchett JC, Rogez S, Chromosomally integrated human herpesvirus 6: questions and answers. Rev Med Virol. 2012 May; 22(3):144-55. Epub 2011 Nov 04.
    View PubMed
  34. Watkins RR, Lemonovich TL, Razonable RR. Immune response to CMV in solid organ transplant recipients: current concepts and future directions. Expert Rev Clin Immunol. 2012 May; 8(4):383-93.
    View PubMed
  35. Grossi PA, Costa AN, Fehily D, Blumberg EA, Kuehnert MJ, Fishman JA, Ison MG, Lattes R, Kotton CN, Lilleri D, Kabanova A, Lanzavecchia A, Gerna G, Razonable RR, Comoli P, Zecca M, Basso S, Ginevri F, Grossi A, Schena FP, Rimola A, Burra P, De Martin E, Ro Infections and organ transplantation: new challenges for prevention and treatment--a colloquium. Transplantation. 2012 Mar 15; 93(5 Suppl):S4-S39.
    View PubMed
  36. Kang SH, Abdel-Massih RC, Brown RA, Dierkhising RA, Kremers WK, Razonable RR. Homozygosity for the toll-like receptor 2 R753Q single-nucleotide polymorphism is a risk factor for cytomegalovirus disease after liver transplantation. J Infect Dis. 2012 Feb 15; 205(4):639-46. Epub 2012 Jan 04.
    View PubMed
  37. Ariza-Heredia E, Razonable RR. Incidental hepatic schistosomiasis in a liver transplant recipient. Transpl Infect Dis. 2012 Feb; 14(1):75-8. Epub 2011 Apr 19.
    View PubMed
  38. Ariza-Heredia EJ, Fishman JE, Cleary T, Smith L, Razonable RR, Abbo L. Clinical and radiological features of respiratory syncytial virus in solid organ transplant recipients: a single-center experience. Transpl Infect Dis. 2012 Feb; 14(1):64-71. Epub 2011 Oct 07.
    View PubMed
  39. Winston DJ Saliba F Blumberg E Abouljoud M Garcia-Diaz JB Goss JA Clough L Avery R Limaye AP Ericzon BG Navasa M Troisi RI Chen H Villano SA Uknis ME, 1263-301 Clinical Study Group (including Razonable RR). Efficacy and safety of maribavir dosed at 100 mg orally twice daily for the prevention of cytomegalovirus disease in liver transplant recipients: a randomized, double-blind, multicenter controlled trial. Amerian Journal of Transplantation. 2012; 12(11):3021-30.
  40. Ariza-Heredia EJ, Dababneh AS, Wilhelm MP, Wengenack NL, Razonable RR, Wilson JW. Mycobacterium wolinskyi: a case series and review of the literature. Diagn Microbiol Infect Dis. 2011 Dec; 71(4):421-7. Epub 2011 Sep 25.
    View PubMed
  41. Razonable RR. Rare, unusual, and less common virus infections after organ transplantation. Curr Opin Organ Transplant. 2011 Dec; 16(6):580-7.
    View PubMed
  42. Razonable RR, Brown RA, Lee SO. Reply to "May the Indirect Effects of CIHHV-6 in Transplant Patients be Exerted Through the Reactivation of the Viral Replicative Machinery?". Transplantation. 2011 Nov 15; 92(9):e51-2.
    View PubMed
  43. Parsaik AK, Bhalla T, Dong M, Rostambeigi N, Dierkhising RA, Dean P, Abraham R, Prieto M, Kremers WK, Razonable RR, Kudva YC. Epidemiology of cytomegalovirus infection after pancreas transplantation. Transplantation. 2011 Nov 15; 92(9):1044-50.
    View PubMed
  44. Ariza-Heredia EJ, Razonable RR. Human herpes virus 8 in solid organ transplantation. Transplantation. 2011 Oct 27; 92(8):837-44.
    View PubMed
  45. Razonable RR. Antiviral drugs for viruses other than human immunodeficiency virus. Mayo Clin Proc. 2011 Oct; 86(10):1009-26.
    View PubMed
  46. Lee SO, Brown RA, Kang SH, Abdel Massih RC, Razonable RR. Toll-like receptor 4 polymorphisms and the risk of gram-negative bacterial infections after liver transplantation. Transplantation. 2011 Sep 27; 92(6):690-6.
    View PubMed
  47. Lee SO, Brown RA, Kang SH, Abdel-Massih RC, Razonable RR. Toll-like receptor 2 polymorphism and Gram-positive bacterial infections after liver transplantation. Liver Transpl. 2011 Sep; 17(9):1081-8.
    View PubMed
  48. Romero FA, Deziel PJ, Razonable RR. Majocchi's granuloma in solid organ transplant recipients. Transpl Infect Dis. 2011 Aug; 13(4):424-32. Epub 2011 Jan 27.
    View PubMed
  49. Lee SO, Brown RA, Razonable RR. Clinical significance of pretransplant chromosomally integrated human herpesvirus-6 in liver transplant recipients. Transplantation. 2011 Jul 27; 92(2):224-9.
    View PubMed
  50. Lee SO, Brown RA, Eid AJ, Razonable RR. Chromosomally integrated human herpesvirus-6 in kidney transplant recipients. Nephrol Dial Transplant. 2011 Jul; 26(7):2391-3. Epub 2011 May 12.
    View PubMed
  51. El Helou OC, Berbari EF, Lahr BD, Marculescu CE, Razonable RR, Steckelberg JM, Hanssen AD, Osmon DR. Management of prosthetic joint infection treated with two-stage exchange: the impact of antimicrobial therapy duration. Curr. Orthop. Pract. 2011 Jul-Aug; 22(4):333-8.
  52. Al-Hasan MN, Razonable RR, Kremers WK, Baddour LM. Impact of Gram-negative bloodstream infection on long-term allograft survival after kidney transplantation. Transplantation. 2011 Jun 15; 91(11):1206-10.
    View PubMed
  53. Razonable RR. Management of viral infections in solid organ transplant recipients. Expert Rev Anti Infect Ther. 2011 Jun; 9(6):685-700.
    View PubMed
  54. Lee SO, Kang SH, Abdel-Massih RC, Brown RA, Razonable RR. Spectrum of early-onset and late-onset bacteremias after liver transplantation: implications for management. Liver Transpl. 2011 Jun; 17(6):733-41.
    View PubMed
  55. Razonable RR, Findlay JY, O'Riordan A, Burroughs SG, Ghobrial RM, Agarwal B, Davenport A, Gropper M. Critical care issues in patients after liver transplantation. Liver Transpl. 2011 May; 17(5):511-27.
    View PubMed
  56. Romero FA, Razonable RR. Infections in liver transplant recipients. World J Hepatol. 2011 Apr 27; 3(4):83-92.
    View PubMed
  57. Wermers RA, Cooper K, Razonable RR, Deziel PJ, Whitford GM, Kremers WK, Moyer TP. Fluoride excess and periostitis in transplant patients receiving long-term voriconazole therapy. Clin Infect Dis. 2011 Mar 1; 52(5):604-11. Epub 2011 Jan 16.
    View PubMed
  58. Hebart H, Lengerke C, Ljungman P, Paya CV, Klingebiel T, Loeffler J, Pfaffenrath S, Lewensohn-Fuchs I, Barkholt L, Tomiuk J, Meisner C, Lunenberg J, Top B, Razonable RR, Patel R, Litzow MR, Jahn G, Einsele H. Prospective comparison of PCR-based vs late mRNA-based preemptive antiviral therapy for HCMV infection in patients after allo-SCT. Bone Marrow Transplant. 2011 Mar; 46(3):408-15. Epub 2010 Jun 28.
    View PubMed
  59. El-Helou O, Berbari EF, Brown RA, Gralewski JH, Osmon DR, Razonable RR. Functional assessment of Toll-like receptor 2 and its relevance in patients with Staphylococcus aureus infection of joint prosthesis. Hum Immunol. 2011 Jan; 72(1):47-53. Epub 2010 Oct 28.
    View PubMed
  60. Ariza-Heredia E, Razonable RR. HHV-8 in solid organ transplantation. Transplantation (Accepted and In Press). 2011.
  61. Razonable RR. Infections due to human herpesvirus 6 in solid organ transplant recipients. Curr Opin Organ Transplant. 2010 Dec; 15(6):671-5.
    View PubMed
  62. Sun HY, Alexander BD, Lortholary O, Dromer F, Forrest GN, Lyon GM, Somani J, Gupta KL, del Busto R, Pruett TL, Sifri CD, Limaye AP, John GT, Klintmalm GB, Pursell K, Stosor V, Morris MI, Dowdy LA, Munoz P, Kalil AC, Garcia-Diaz J, Orloff SL, House AA, Unrecognized pretransplant and donor-derived cryptococcal disease in organ transplant recipients. Clin Infect Dis. 2010 Nov 1; 51(9):1062-9.
    View PubMed
  63. Razonable RR. Cytomegalovirus infection after liver transplantation. Liver Transpl. 2010 Oct; 16(S2):S45-53.
    View PubMed
  64. Osawa R, Alexander BD, Forrest GN, Lyon GM, Somani J, del Busto R, Pruett TL, Sifri CD, Limaye AP, Klintmalm GB, Pursell K, Stosor V, Morris MI, Dowdy LA, Kalil AC, Garcia-Diaz J, Orloff SL, Houston SH, Wray D, Huprikar S, Johnson LB, Razonable RR, Geographic differences in disease expression of cryptococcosis in solid organ transplant recipients in the United States. Ann Transplant. 2010 Oct-Dec; 15(4):77-83.
    View PubMed
  65. Lee SO, Razonable RR. Current concepts on cytomegalovirus infection after liver transplantation. World J Hepatol. 2010 Sep 27; 2(9):325-36.
    View PubMed
  66. Razonable RR, Lautenschlager I. Impact of human herpes virus 6 in liver transplantation. World J Hepatol. 2010 Sep 27; 2(9):345-53.
    View PubMed
  67. Boucher H, Miller LG, Razonable RR. Serious infections caused by methicillin-resistant Staphylococcus aureus. Clin Infect Dis. 2010 Sep 15; 51 Suppl 2:S183-97.
    View PubMed
  68. Sun HY, Alexander BD, Lortholary O, Dromer F, Forrest GN, Lyon GM, Somani J, Gupta KL, Del Busto R, Pruett TL, Sifri CD, Limaye AP, John GT, Klintmalm GB, Pursell K, Stosor V, Morris MI, Dowdy LA, Munoz P, Kalil AC, Garcia-Diaz J, Orloff SL, House AA, Cutaneous cryptococcosis in solid organ transplant recipients. Med Mycol. 2010 Sep; 48(6):785-91.
    View PubMed
  69. Razonable RR. Strategies for managing cytomegalovirus in transplant recipients. Expert Opin Pharmacother. 2010 Aug; 11(12):1983-97.
    View PubMed
  70. El Helou OC, Berbari EF, Lahr BD, Eckel-Passow JE, Razonable RR, Sia IG, Virk A, Walker RC, Steckelberg JM, Wilson WR, Hanssen AD, Osmon DR. Efficacy and safety of rifampin containing regimen for staphylococcal prosthetic joint infections treated with debridement and retention. Eur J Clin Microbiol Infect Dis. 2010 Aug; 29(8):961-7. Epub 2010 May 27.
    View PubMed
  71. Kumar D, Michaels MG, Morris MI, Green M, Avery RK, Liu C, Danziger-Isakov L, Stosor V, Estabrook M, Gantt S, Marr KA, Martin S, Silveira FP, Razonable RR, Allen UD, Levi ME, Lyon GM, Bell LE, Huprikar S, Patel G, Gregg KS, Pursell K, Helmersen D, Julian Outcomes from pandemic influenza A H1N1 infection in recipients of solid-organ transplants: a multicentre cohort study. Lancet Infect Dis. 2010 Aug; 10(8):521-6. Epub 2010 Jul 09.
    View PubMed
  72. Brown RA, Razonable RR. A real-time PCR assay for the simultaneous detection of functional N284I and L412F polymorphisms in the human Toll-like receptor 3 gene. J Mol Diagn. 2010 Jul; 12(4):493-7. Epub 2010 Apr 22.
    View PubMed
  73. Boyce RD, Deziel PJ, Otley CC, Wilhelm MP, Eid AJ, Wengenack NL, Razonable RR. Phaeohyphomycosis due to Alternaria species in transplant recipients. Transpl Infect Dis. 2010 Jun; 12(3):242-50. Epub 2009 Dec 09.
    View PubMed
  74. Eid AJ, Razonable RR. New developments in the management of cytomegalovirus infection after solid organ transplantation. Drugs. 2010 May 28; 70(8):965-81.
    View PubMed
  75. Eid AJ, Brown RA, Arthurs SK, Lahr BD, Eckel-Passow JE, Larson TS, Razonable RR. A prospective longitudinal analysis of cytomegalovirus (CMV)-specific CD4+ and CD8+ T cells in kidney allograft recipients at risk of CMV infection. Transpl Int. 2010 May 1; 23(5):506-13. Epub 2009 Nov 27.
    View PubMed
  76. Arthurs SK, Eid AJ, Deziel PJ, Marshall WF, Cassivi SD, Walker RC, Razonable RR. The impact of invasive fungal diseases on survival after lung transplantation. Clin Transplant. 2010 May-Jun; 24(3):341-8. Epub 2009 Aug 27.
    View PubMed
  77. Brown RA, Gralewski JH, Eid AJ, Knoll BM, Finberg RW, Razonable RR. R753Q single-nucleotide polymorphism impairs toll-like receptor 2 recognition of hepatitis C virus core and nonstructural 3 proteins. Transplantation. 2010 Apr 15; 89(7):811-5.
    View PubMed
  78. Kotton CN, Kumar D, Caliendo AM, Asberg A, Chou S, Snydman DR, Allen U, Humar A, Transplantation Society International CMV Consensus Group. International consensus guidelines on the management of cytomegalovirus in solid organ transplantation. Transplantation. 2010 Apr 15; 89(7):779-95.
    View PubMed
  79. Osawa R, Alexander BD, Lortholary O, Dromer F, Forrest GN, Lyon GM, Somani J, Gupta KL, Del Busto R, Pruett TL, Sifri CD, Limaye AP, John GT, Klintmalm GB, Pursell K, Stosor V, Morris MI, Dowdy LA, Munoz P, Kalil AC, Garcia-Diaz J, Orloff S, House AA, Identifying predictors of central nervous system disease in solid organ transplant recipients with cryptococcosis. Transplantation. 2010 Jan 15; 89(1):69-74.
    View PubMed
  80. Razonable RR. Immune-based therapies for cytomegalovirus infection. Immunotherapy. 2010 Jan; 2(1):117-30.
    View PubMed
  81. Eid AJ, Arthurs SK, Deziel PJ, Wilhelm MP, Razonable RR. Clinical predictors of relapse after treatment of primary gastrointestinal cytomegalovirus disease in solid organ transplant recipients. Am J Transplant. 2010 Jan; 10(1):157-61. Epub 2009 Nov 04.
    View PubMed
  82. Sun HY, Alexander BD, Lortholary O, Dromer F, Forrest GN, Lyon GM, Somani J, Gupta KL, del Busto R, Pruett TL, Sifri CD, Limaye AP, John GT, Klintmalm GB, Pursell K, Stosor V, Morris MI, Dowdy LA, Munoz P, Kalil AC, Garcia-Diaz J, Orloff S, House AA, Lipid formulations of amphotericin B significantly improve outcome in solid organ transplant recipients with central nervous system cryptococcosis. Clin Infect Dis. 2009 Dec 1; 49(11):1721-8.
    View PubMed
  83. Eid AJ, Brown RA, Hogan WJ, Lahr BD, Eckel-Passow JE, Litzow MR, Razonable RR. Kinetics of interferon-gamma producing cytomegalovirus (CMV)-specific CD4+ and CD8+ T lymphocytes and the risk of subsequent CMV viremia after allogeneic hematopoietic stem cell transplantation. Transpl Infect Dis. 2009 Dec; 11(6):519-28. Epub 2009 Sep 09.
    View PubMed
  84. Razonable RR, Zerr DM, AST Infectious Diseases Community of Practice. HHV-6, HHV-7 and HHV-8 in solid organ transplant recipients. Am J Transplant. 2009 Dec; 9 Suppl 4:S97-100.
    View PubMed
  85. Razonable RR, Zerr DM, AST Infectious Diseases Community of Practice. HHV-6, HHV-7 and HHV-8 in solid organ transplant recipients. Am J Transplant. 2009 Dec; 9 Suppl 4:S100-3.
    View PubMed
  86. Razonable RR, Eid AJ. Viral infections in transplant recipients. Minerva Med. 2009 Dec; 100(6):479-501.
    View PubMed
  87. Brown RA, Gralewski JH, Razonable RR. The R753Q polymorphism abrogates toll-like receptor 2 signaling in response to human cytomegalovirus. Clin Infect Dis. 2009 Nov 1; 49(9):e96-9.
    View PubMed
  88. Abdel Massih RC, Razonable RR. Human herpesvirus 6 infections after liver transplantation. World J Gastroenterol. 2009 Jun 7; 15(21):2561-9.
    View PubMed
  89. Razonable RR. Cytomegalovirus infection in solid organ transplant recipients. Johns Hopkins eTransplant ID Review. 2009 June Epub 2009 Jun.
  90. Larson AN, Razonable RR, Hanssen AD. Capnocytophaga canimorsus a novel pathogen for joint arthroplasty. Clin Orthop Relat Res. 2009 Jun; 467(6):1634-8. Epub 2008 Dec 09.
    View PubMed
  91. Al-Hasan MN, Razonable RR, Eckel-Passow JE, Baddour LM. Incidence rate and outcome of Gram-negative bloodstream infection in solid organ transplant recipients. Am J Transplant. 2009 Apr; 9(4):835-43.
    View PubMed
  92. Cummins NW, Deziel PJ, Abraham RS, Razonable RR. Deficiency of cytomegalovirus (CMV)-specific CD8+ T cells in patients presenting with late-onset CMV disease several years after transplantation. Transpl Infect Dis. 2009 Feb; 11(1):20-7. Epub 2008 Sep 21.
    View PubMed
  93. Razonable RR. Management of cytomegalovirus infection after renal transplantation. IDCP. 2009; 17(4):220-30.
    View PubMed
  94. Razonable RR, Pulido JS, Deziel PJ, Dev S, Salomao DR, Walker RC. Chorioretinitis and vitreitis due to Tropheryma whipplei after transplantation: case report and review. Transpl Infect Dis. 2008 Dec; 10(6):413-8. Epub 2008 Jun 18.
    View PubMed
  95. El Helou OC, Berbari EF, Marculescu CE, El Atrouni WI, Razonable RR, Steckelberg JM, Hanssen AD, Osmon DR. Outcome of enterococcal prosthetic joint infection: is combination systemic therapy superior to monotherapy? Clin Infect Dis. 2008 Oct 1; 47(7):903-9.
    View PubMed
  96. Pandian TK, Deziel PJ, Otley CC, Eid AJ, Razonable RR. Mycobacterium marinum infections in transplant recipients: case report and review of the literature. Transpl Infect Dis. 2008 Oct; 10(5):358-63. Epub 2008 May 15.
    View PubMed
  97. Arthurs SK, Eid AJ, Pedersen RA, Kremers WK, Cosio FG, Patel R, Razonable RR. Delayed-onset primary cytomegalovirus disease and the risk of allograft failure and mortality after kidney transplantation. Clin Infect Dis. 2008 Mar 15; 46(6):840-6.
    View PubMed
  98. Eid AJ, Arthurs SK, Deziel PJ, Wilhelm MP, Razonable RR. Emergence of drug-resistant cytomegalovirus in the era of valganciclovir prophylaxis: therapeutic implications and outcomes. Clin Transplant. 2008 Mar-Apr; 22(2):162-70.
    View PubMed
  99. Eid AJ, Bakri SJ, Kijpittayarit S, Razonable RR. Clinical features and outcomes of cytomegalovirus retinitis after transplantation. Transpl Infect Dis. 2008 Feb; 10(1):13-8. Epub 2007 May 19.
    View PubMed
  100. Pandian TK, Razonable RR. Bidirectional interaction between cytomegalovirus and hepatitis C virus after liver transplantation: A critical review of the clinical evidence. Trends in Transplantation. 2008; 3:35-43.
  101. Eid AJ, Paya CV, Razonable RR. Optimal length of valganciclovir prophylaxis after solid organ transplantation. Trends in Transplantation. 2008; 2(2):92-100.
  102. Cascalho M, Ogle BM, Razonable RR, West LJ, Platt JL. Cardiac transplantation in infancy: A model for dissecting immunological function. Paediatr Child Health. 2008; 18(Suppl 1):S30-S32.
  103. Eid AJ, Razonable RR. Cytomegalovirus disease in solid organ transplant recipients: advances lead to new challenges and opportunities. Curr Opin Organ Transplant. 2007 Dec; 12(6):610-7.
    View PubMed
  104. Arthurs SK, Eid AJ, Pedersen RA, Dierkhising RA, Kremers WK, Patel R, Razonable RR. Delayed-onset primary cytomegalovirus disease after liver transplantation. Liver Transpl. 2007 Dec; 13(12):1703-9.
    View PubMed
  105. Humar A, Washburn K, Freeman R, Paya CV, Mouas H, Alecock E, Razonable RR, PV16000 Study Group. An assessment of interactions between hepatitis C virus and herpesvirus reactivation in liver transplant recipients using molecular surveillance. Liver Transpl. 2007 Oct; 13(10):1422-7.
    View PubMed
  106. Kijpittayarit-Arthurs S, Eid AJ, Kremers WK, Pedersen RA, Dierkhising RA, Patel R, Razonable RR. Clinical features and outcomes of delayed-onset primary cytomegalovirus disease in cardiac transplant recipients. J Heart Lung Transplant. 2007 Oct; 26(10):1019-24.
    View PubMed
  107. Eid AJ, Davis MD, Bingham LG, Kalaaji AN, Enzler M, Razonable RR, Berbari EF. A young man with pyomyositis and bullous disease. Clin Infect Dis. 2007 Sep 15; 45(6):741, 799-800.
    View PubMed
  108. Eid AJ, Berbari EF, Sia IG, Wengenack NL, Osmon DR, Razonable RR. Prosthetic joint infection due to rapidly growing mycobacteria: report of 8 cases and review of the literature. Clin Infect Dis. 2007 Sep 15; 45(6):687-94. Epub 2007 Aug 13.
    View PubMed
  109. Eid AJ, Brown RA, Paya CV, Razonable RR. Association between toll-like receptor polymorphisms and the outcome of liver transplantation for chronic hepatitis C virus. Transplantation. 2007 Aug 27; 84(4):511-6.
    View PubMed
  110. Viscount HB, Eid AJ, Espy MJ, Griffin MD, Thomsen KM, Harmsen WS, Razonable RR, Smith TF. Polyomavirus polymerase chain reaction as a surrogate marker of polyomavirus-associated nephropathy. Transplantation. 2007 Aug 15; 84(3):340-5.
    View PubMed
  111. Eid AJ, Razonable RR. Valganciclovir for the treatment of cytomegalovirus retinitis in patients with AIDS. Expert Review of Ophthalmology. 2007 Jun; 2(3):351-61.
  112. Bonatti H, Sawyer R, Dickson RC, Razonable R, Schmitt T, Mendez J, Singh N, Pruett T. Transmission of viral disease to the recipient through the donor liver. Current Opinion in Organ Transplantation. 2007 Jun; 12(3):231-41.
    View PubMed
  113. Kijpittayarit S, Eid AJ, Brown RA, Paya CV, Razonable RR. Relationship between Toll-like receptor 2 polymorphism and cytomegalovirus disease after liver transplantation. Clin Infect Dis. 2007 May 15; 44(10):1315-20.
    View PubMed
  114. Kijpittayarit S, Razonable RR. JC virus infection after transplantation: Beyond the classic progressive multifocal leukoencephalopathy? Gastroenterol Hepatol. 2007 Jan; 3(1):74-6.
    View PubMed
  115. Assi MA, Pulido JS, Peters SG, McCannel CA, Razonable RR. Graft-vs.-host disease in lung and other solid organ transplant recipients. Clin Transplant. 2007 Jan-Feb; 21(1):1-6.
    View PubMed
  116. Anaissie EJ, Segal BH, Graybill JR, Arndt C, Perfect JR, Kleinberg M, Pappas P, Benjamin D, Rubin R, Aberg JA, Adderson EE, Adler-Shohet FC, Akan H, Akova M, Almyroudis NG, Alexander BD, Andes D, Arrieta A, Baddley JW, Barron MA, Belzberg H, Boucher HW, Clinical research in the lay press: irresponsible journalism raises a huge dose of doubt. Clin Infect Dis. 2006 Oct 15; 43(8):1031-9. Epub 2006 Sep 13.
    View PubMed
  117. Eid AJ, Brown RA, Patel R, Razonable RR. Parvovirus B19 infection after transplantation: a review of 98 cases. Clin Infect Dis. 2006 Jul 1; 43(1):40-8. Epub 2006 May 12.
    View PubMed
  118. Ogle BM, West LJ, Driscoll DJ, Strome SE, Razonable RR, Paya CV, Cascalho M, Platt JL. Effacing of the T cell compartment by cardiac transplantation in infancy. J Immunol. 2006 Feb 1; 176(3):1962-7.
    View PubMed
  119. Razonable RR, Henault M, Paya CV. Stimulation of toll-like receptor 2 with bleomycin results in cellular activation and secretion of pro-inflammatory cytokines and chemokines. Toxicol Appl Pharmacol. 2006 Feb 1; 210(3):181-9. Epub 2005 Jun 17.
    View PubMed
  120. Razonable RR, Brown RA, Humar A, Covington E, Alecock E, Paya CV. Herpesvirus infections in solid organ transplant patients at high risk of primary cytomegalovirus disease. J Infect Dis. 2005 Oct 15; 192(8):1331-9.
    View PubMed
  121. Razonable RR, Brown RA, Humar A, Covington E, Alecock E, Paya CV. A longitudinal molecular surveillance study of human polyomavirus viremia in heart, kidney, liver, and pancreas transplant patients. J Infect Dis. 2005 Oct 15; 192(8):1349-54.
    View PubMed
  122. Humar A, Kumar D, Mazzulli T, Razonable RR, Moussa G, Paya CV, Covington E, Alecock E, Pescovitz MD. A surveillance study of adenovirus infection in adult solid organ transplant recipients. Am J Transplant. 2005 Oct; 5(10):2555-9.
    View PubMed
  123. Razonable RR, Henault M, Watson HL, Paya CV. Nystatin induces secretion of interleukin (IL)-1beta, IL-8, and tumor necrosis factor alpha by a toll-like receptor-dependent mechanism. Antimicrob Agents Chemother. 2005 Aug; 49(8):3546-9.
    View PubMed
  124. Zamora MR, Davis RD, Leonard C, CMV Advisory Board Expert Committee. Management of cytomegalovirus infection in lung transplant recipients: evidence-based recommendations. Transplantation. 2005 Jul 27; 80(2):157-63.
    View PubMed
  125. Humar A, Mazzulli T, Moussa G, Razonable RR, Paya CV, Pescovitz MD, Covington E, Alecock E. Clinical utility of cytomegalovirus (CMV) serology testing in high-risk CMV D+/R- transplant recipients. Am J Transplant. 2005 May; 5(5):1065-70.
    View PubMed
  126. Razonable RR, Henault M, Lee LN, Laethem C, Johnston PA, Watson HL, Paya CV. Secretion of proinflammatory cytokines and chemokines during amphotericin B exposure is mediated by coactivation of toll-like receptors 1 and 2. Antimicrob Agents Chemother. 2005 Apr; 49(4):1617-21.
    View PubMed
  127. Razonable RR, Emery VC, 11th Annual Meeting of the IHMF (International Herpes Management Forum). Management of CMV infection and disease in transplant patients. 27-29 February 2004. Herpes. 2004 Dec; 11(3):77-86.
    View PubMed
  128. Razonable RR, Osmon DR, Steckelberg JM. Linezolid therapy for orthopedic infections. Mayo Clin Proc. 2004 Sep; 79(9):1137-44.
    View PubMed
  129. Razonable RR, Paya CV. Valganciclovir for the prevention and treatment of cytomegalovirus disease in immunocompromised hosts. Expert Rev Anti Infect Ther. 2004 Feb; 2(1):27-41.
    View PubMed
  130. Razonable RR, Paya CV. Herpesvirus infections in transplant recipients: current challenges in the clinical management of cytomegalovirus and Epstein-Barr virus infections. Herpes. 2003 Dec; 10(3):60-5.
    View PubMed
  131. Razonable RR, Rahman AE, Wilson WR. Lemierre syndrome variant: necrobacillosis associated with inferior vena cava thrombosis and pulmonary abscesses after trauma-induced leg abscess. Mayo Clin Proc. 2003 Sep; 78(9):1153-6.
    View PubMed
  132. Razonable RR, van Cruijsen H, Brown RA, Wilson JA, Harmsen WS, Wiesner RH, Smith TF, Paya CV. Dynamics of cytomegalovirus replication during preemptive therapy with oral ganciclovir. J Infect Dis. 2003 Jun 1; 187(11):1801-8. Epub 2003 May 09.
    View PubMed
  133. Feldstein AE, Razonable RR, Boyce TG, Freese DK, El-Youssef M, Perrault J, Paya CV, Ishitani MB. Prevalence and clinical significance of human herpesviruses 6 and 7 active infection in pediatric liver transplant patients. Pediatr Transplant. 2003 Apr; 7(2):125-9.
    View PubMed
  134. Razonable RR, Rivero A, Brown RA, Hart GD, Espy MJ, van Cruijsen H, Wilson J, Groettum C, Kremers W, Smith TF, Paya CV. Detection of simultaneous beta-herpesvirus infections in clinical syndromes due to defined cytomegalovirus infection. Clin Transplant. 2003 Apr; 17(2):114-20.
    View PubMed
  135. Razonable RR, Burak KW, van Cruijsen H, Brown RA, Charlton MR, Smith TF, Espy MJ, Kremers W, Wilson JA, Groettum C, Wiesner R, Paya CV. The pathogenesis of hepatitis C virus is influenced by cytomegalovirus. Clin Infect Dis. 2002 Oct 15; 35(8):974-81.
    View PubMed
  136. Razonable RR, Paya CV. beta-Herpesviruses in transplantation. Reviews in Medical Microbiology. 2002 Oct; 13(4):163-76.
    View PubMed
  137. Razonable RR, Paya CV. The impact of human herpesvirus-6 and-7 infection on the outcome of liver transplantation. Liver Transpl. 2002 Aug; 8(8):651-8.
    View PubMed
  138. Razonable RR, Litzow MR, Khaliq Y, Piper KE, Rouse MS, Patel R. Bacteremia due to viridans group Streptococci with diminished susceptibility to Levofloxacin among neutropenic patients receiving levofloxacin prophylaxis. Clin Infect Dis. 2002 Jun 1; 34(11):1469-74. Epub 2002 May 07.
    View PubMed
  139. Burak KW, Kremers WK, Batts KP, Wiesner RH, Rosen CB, Razonable RR, Paya CV, Charlton MR. Impact of cytomegalovirus infection, year of transplantation, and donor age on outcomes after liver transplantation for hepatitis C. Liver Transpl. 2002 Apr; 8(4):362-9.
    View PubMed
  140. Razonable RR, Brown RA, Wilson J, Groettum C, Kremers W, Espy M, Smith TF, Paya CV. The clinical use of various blood compartments for cytomegalovirus (CMV) DNA quantitation in transplant recipients with CMV disease. Transplantation. 2002 Mar 27; 73(6):968-73.
    View PubMed
  141. Razonable RR, Paya CV, Smith TF. Role of the laboratory in diagnosis and management of cytomegalovirus infection in hematopoietic stem cell and solid-organ transplant recipients. J Clin Microbiol. 2002 Mar; 40(3):746-52.
    View PubMed
  142. Razonable RR, Fanning C, Brown RA, Espy MJ, Rivero A, Wilson J, Kremers W, Smith TF, Paya CV. Selective reactivation of human herpesvirus 6 variant a occurs in critically ill immunocompetent hosts. J Infect Dis. 2002 Jan 1; 185(1):110-3. Epub 2001 Dec 14.
    View PubMed
  143. Razonable RR, Paya CV. Fungal infections in liver transplantation: Prophylaxis, surveillance, and treatment. Current Opinion in Organ Transplantation. 2002; 7(2):137-43.
    View PubMed
  144. Razonable RR, Rivero A, Rodriguez A, Wilson J, Daniels J, Jenkins G, Larson T, Hellinger WC, Spivey JR, Paya CV. Allograft rejection predicts the occurrence of late-onset cytomegalovirus (CMV) disease among CMV-mismatched solid organ transplant patients receiving prophylaxis with oral ganciclovir. J Infect Dis. 2001 Dec 1; 184(11):1461-4. Epub 2001 Oct 23.
    View PubMed
  145. Razonable RR, Brown RA, Espy MJ, Rivero A, Kremers W, Wilson J, Groettum C, Smith TF, Paya CV. Comparative quantitation of cytomegalovirus (CMV) DNA in solid organ transplant recipients with CMV infection by using two high-throughput automated systems. J Clin Microbiol. 2001 Dec; 39(12):4472-6.
    View PubMed
  146. Razonable RR, Aksamit AJ, Wright AJ, Wilson JW. Cidofovir treatment of progressive multifocal leukoencephalopathy in a patient receiving highly active antiretroviral therapy. Mayo Clin Proc. 2001 Nov; 76(11):1171-5.
    View PubMed
  147. Razonable RR, Lewallen DG, Patel R, Osmon DR. Vertebral osteomyelitis and prosthetic joint infection due to Staphylococcus simulans. Mayo Clin Proc. 2001 Oct; 76(10):1067-70.
    View PubMed
  148. Razonable RR, Patel R, Wilhelm MP, Gertz MA, Litzow MR, Inwards DJ, Dearani JA, Edwards BS, McGregor CG. Fatal disseminated aspergillosis following sequential heart and stem cell transplantation for systemic amyloidosis. Am J Transplant. 2001 May; 1(1):93-5.
    View PubMed